Anti‐rubella IgG serum levels predict risk for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) breakthrough infections.

MLA

Hollstein, Moritz M., et al. “Anti‐rubella IgG Serum Levels Predict Risk for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Breakthrough Infections.” Allergy, vol. 79, no. 11, Nov. 2024, pp. 3154–56. EBSCOhost, https://doi.org/10.1111/all.16232.

APA

Hollstein, M. M., Dierks, S., Schön, M. P., Groß, U., Thiele, K., Leha, A., Zautner, A. E., Fischer, A., Erpenbeck, L., & Schnelle, M. (2024). Anti‐rubella IgG serum levels predict risk for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) breakthrough infections. Allergy, 79(11), 3154–3156. https://doi.org/10.1111/all.16232

Chicago

Hollstein, Moritz M., Sascha Dierks, Michael P. Schön, Uwe Groß, Karin Thiele, Andreas Leha, Andreas E. Zautner, Andreas Fischer, Luise Erpenbeck, and Moritz Schnelle. 2024. “Anti‐rubella IgG Serum Levels Predict Risk for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Breakthrough Infections.” Allergy 79 (11): 3154–56. doi:10.1111/all.16232.